Literature DB >> 12629091

Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia.

Sheri A Berenbaum1, J Michael Bailey.   

Abstract

To address questions about sex assignment in children with ambiguous genitalia, we studied gender identity in girls with congenital adrenal hyperplasia (CAH) in relation to characteristics of the disease and treatment, particularly genital appearance and surgery. A 9-item gender identity interview was administered to 43 girls with classical CAH ranging in age from 3-18 yr, 7 tomboys, and 29 sister control girls. Groups were compared on total score and on individual items. Results showed that, on the total gender identity score, 88% of girls with CAH had scores overlapping those of control girls, but the average score was intermediate between control girls and tomboys. On individual items of gender identity (discomfort as a girl, wish to be a boy), girls with CAH were similar to control girls. Gender identity in girls with CAH was not related to degree of genital virilization or age at which genital reconstructive surgery was done. Thus, moderate androgen excess early in development appears to produce a small increase in the risk of atypical gender identity, but this risk cannot be predicted from genital virilization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629091     DOI: 10.1210/jc.2002-020782

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

1.  Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth.

Authors:  William G Reiner; John P Gearhart
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

2.  Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects.

Authors:  D K Gupta; Sharma Shilpa; A C Amini; M Gupta; Gautam Aggarwal; Gupta Deepika; Khatri Kamlesh
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

3.  Beyond Pink and Blue: The Complexity of Early Androgen Effects on Gender Development.

Authors:  Sheri A Berenbaum
Journal:  Child Dev Perspect       Date:  2017-11-01

4.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

5.  Gender identity shows a high correlation with Prader score in patients with disorders of sex development (DSD) presenting in mid childhood.

Authors:  Tanvir K Chowdhury; Md Zonaid Chowdhury; Fahmida Mili; John M Hutson; Tahmina Banu
Journal:  Pediatr Surg Int       Date:  2014-02-25       Impact factor: 1.827

Review 6.  Intersex and gender assignment; the third way?

Authors:  S F Ahmed; S Morrison; I A Hughes
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

7.  Health-related quality of life in children with disorders of sex development (DSD).

Authors:  Martina Jürgensen; Anke Lux; Sebastian Benedikt Wien; Eva Kleinemeier; Olaf Hiort; Ute Thyen
Journal:  Eur J Pediatr       Date:  2014-01-28       Impact factor: 3.183

8.  Nonclassic congenital adrenal hyperplasia.

Authors:  Selma Feldman Witchel; Ricardo Azziz
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-30

9.  A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-30

10.  Clinical evaluation study of the German network of disorders of sex development (DSD)/intersexuality: study design, description of the study population, and data quality.

Authors:  Anke Lux; Siegfried Kropf; Eva Kleinemeier; Martina Jürgensen; Ute Thyen
Journal:  BMC Public Health       Date:  2009-04-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.